{
  "docId": "019dd923-622c-750b-8b99-9ee2a1e788fb",
  "docSlug": "1233d0b05ad9",
  "documentTitle": "PROCEPT BioRobotics Corporation (PRCT)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Spruce Point Capital Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-01-16 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 66,
  "pageCount": 100,
  "prevPage": 65,
  "nextPage": 67,
  "slideType": "quote_slide",
  "function": "cite_precedent",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": "The slide uses red text to highlight key critical arguments within the quote.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "callout_box",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b99-9ee2a1e788fb/66",
  "deckHref": "/decks/019dd923-622c-750b-8b99-9ee2a1e788fb",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b99-9ee2a1e788fb.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b99-9ee2a1e788fb#slide-66",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Discussions with numerous urologists supported our thesis that (1) Procept cannot address the entire BPH patient population with equal competitiveness, (2) any trend toward earlier treatment (of smaller prostates, by definition) disadvantages Procept, and (3) Aquablation is most competitive with larger prostates, which represents the smaller segment of the BPH market.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-ee36-760b-929a-feb8a756e568",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.96,
        "x": 0.02,
        "y": 0.17
      },
      "kind": "paragraph",
      "text": "Discussions with numerous urologists supported our thesis that (1) Procept cannot address the entire BPH patient population with equal competitiveness, (2) any trend toward earlier treatment (of smaller prostates, by definition) disadvantages Procept, and (3) Aquablation is most competitive with larger prostates, which represents the smaller segment of the BPH market.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "76b390eb-477c-4845-ac4f-f2620c1a0b6a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.73,
        "x": 0.25,
        "y": 0.32
      },
      "kind": "quote",
      "text": "But as you skew younger, you're going to have guys that are more interested in less invasive procedures... smaller prostates in general are better fits for minimally invasive procedures than something like Procept... Procept will struggle in the younger guys, smaller prostates. I'd say somewhere between 10%, maybe, maybe 15% [of my patients] are in that very large category... realistically, they're rare. ...what's not being communicated there is that all of the value of Procept is in bigger prostates.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5e5fbe53-1b1a-4a5a-937e-ad625400e17b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "But as you skew younger, you're going to have guys that are more interested in less invasive procedures. You're also have on the whole smaller prostates, and smaller prostates in general are better fits for minimally invasive procedures than something like Procept. The big, big value of Procept is in larger prostates. They may tell you different, but the reality is that that's where Procept really shines... But I think Procept will struggle in the younger guys, smaller prostates. — Spruce Point Interview with Private Practice Urologist, Dec 2024",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd952-ee36-760b-929b-035410b15895",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.2,
        "x": 0.03,
        "y": 0.33
      },
      "kind": "source-note",
      "text": "Spruce Point Interview with Private Practice Urologist, Dec 2024",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0545f34a-5262-44aa-bf3c-bbbb6e3c17e8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.15,
        "x": 0.02,
        "y": 0.97
      },
      "kind": "source-note",
      "text": "Source: Spruce Point research",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6503adf8-16ba-4a8c-9a26-08806cebb2e6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.65,
        "x": 0.305,
        "y": 0.03
      },
      "kind": "title",
      "text": "A Urologist Expands On Early Treatment And Where Procept Is Most Competitive",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "180c526e-096e-417d-b47c-246a91d87637",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.96,
        "x": 0.02,
        "y": 0.27
      },
      "kind": "title",
      "text": "Urologist Perspectives on the BPH Treatment Paradigm and Implications For Procept",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b0d1c3b3-b8aa-4136-b23a-0059789667c5",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 70,
      "from": 66,
      "name": "Voice Of Customer",
      "slug": "51-voice-of-customer",
      "bestFor": "Product strategy, customer experience, market research",
      "matchId": "17e1ec21-2bd1-4ff1-b983-f7997063a070",
      "evidence": "Quotes and testimonials from urologists and analysts",
      "position": 2,
      "objective": "Highlighting the concerns and skepticism of urologists and investors",
      "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response",
      "confidence": 0.7,
      "description": "Let customer quotes and feedback drive the narrative and validate the insight"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}